Last update Dec. 19, 2013
It is a μ-opioid receptor antagonist that accelerates intestinal transit. Prescribed after intestinal surgery procedures.
Since oral absorption and plasma levels are very low secretion into breast milk is thought to be minimal.
We do not have alternatives for Alvimopan.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.